Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics

ACOR POWR Grades

• Value is the dimension where ACOR ranks best; there it ranks ahead of 80.57% of US stocks.
• The strongest trend for ACOR is in Growth, which has been heading down over the past 106 days.
• ACOR ranks lowest in Growth; there it ranks in the 7th percentile.

ACOR Stock Summary

• ACOR has a higher market value than only 3.78% of US stocks; more precisely, its current market capitalization is $22,127,994.
• With a price/sales ratio of 0.17, Acorda Therapeutics Inc has a higher such ratio than merely 2.3% of stocks in our set.
• Acorda Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 314.78%, greater than the shareholder yield of 99.1% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Acorda Therapeutics Inc, a group of peers worth examining would be AXTA, TWI, ENR, CVV, and FLWS.
• Visit ACOR's SEC page to see the company's official filings. To visit the company's web site, go to www.acorda.com.

ACOR Valuation Summary

• ACOR's price/earnings ratio is -0.4; this is 101.1% lower than that of the median Healthcare stock.
• ACOR's price/earnings ratio has moved up 1.7 over the prior 189 months.
• Over the past 189 months, ACOR's price/earnings ratio has gone up 1.7.

Below are key valuation metrics over time for ACOR.

ACOR Growth Metrics

Its year over year cash and equivalents growth rate is now at 95.67%.
• The 5 year cash and equivalents growth rate now stands at -82.42%.
• Its 3 year net cashflow from operations growth rate is now at -18.06%.

ACOR's revenue has moved down $280,334,000 over the prior 34 months.

The table below shows ACOR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	129.071	-41.348	-103.954
2021-09-30	130.263	-43.14	-166.434
2021-06-30	151.897	-37.033	-132.016
2021-03-31	153.73	-49.115	-126.573
2020-12-31	152.967	-61.006	-99.594
2020-09-30	165.304	-73.883	49.114

ACOR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ACOR has a Quality Grade of C, ranking ahead of 72.56% of graded US stocks.
• ACOR's asset turnover comes in at 0.251 -- ranking 176th of 680 Pharmaceutical Products stocks.
• BDSI, INVA, and CALA are the stocks whose asset turnover ratios are most correlated with ACOR.

The table below shows ACOR's key quality metrics over time.